Novellus Raises $57M!
Novellus, Ltd., a Jerusalem-based clinical-stage biotechnology company focused on precision oncology and cancer treatment, raised $ 57 million in a Series C financing round in a round made at a…
Continue Reading
Novellus Raises $57M!